Written Question · S2W-08184 · Session 2
Further to the answer to question S2W-7671 by Malcolm Chisholm on 5 May 2004, whether it will provide further details of the scientific res…
The question
To ask the Scottish Executive, further to the answer to question S2W-7671 by Malcolm Chisholm on 5 May 2004, whether it will provide further details of the scientific research and evidence to support the statement that the DTwP-Hib vaccine has been demonstrated to give more effective protection against whooping cough (pertussis) than the DTaP-Hib alternative, specifying the author, journal of publication and where the research was conducted.
The answer
The reasons for preferring highquality DTwP products over DTaP vaccine for primary immunisation are fully exploredin the paper Overview of Recent Clinical Trials of Acellular Pertussis Vaccines(Miller E) published in Biologicals (1999) Vol. 27; 79-86. This paper, whichis a review of trials conducted in Sweden, Italy, Senegal and Germany, identified that “with the exception of the five componentvaccine, acellular vaccines are less efficacious than a good whole cell vaccine”.At present, five component acellular vaccines are not available in the UK.
In the Official Report
No contribution in the Official Report cites S2W-08184 by reference.